Literature DB >> 33440460

COVID-19: estimated number of deaths if Australia had experienced a similar outbreak to England and Wales.

Fiona Stanaway1, Les M Irwig1, Armando Teixeira-Pinto1, Katy Jl Bell1.   

Abstract

Entities:  

Keywords:  COVID-19; Infectious diseases; Models; Respiratory tract infections; statistical

Mesh:

Year:  2021        PMID: 33440460      PMCID: PMC8013520          DOI: 10.5694/mja2.50909

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
to the editor: Australia has had a remarkably successful response to coronavirus disease 2019 (COVID‐19), even considering the second wave experienced in Victoria. The Australian rate of COVID‐19‐related deaths of 35 per million population is 15–20 times lower than that observed in countries across Europe and the Americas. However, as the second wave in Melbourne has shown, it is important not to become complacent. Using all‐cause mortality data in England and Wales over the peak of the COVID‐19 outbreak in March and April 2020, we directly estimated the number of excess deaths that might have occurred if the outbreak in Australia had been of a similar extent to that in England and Wales. We estimated the relative risk of all‐cause mortality in England and Wales from the COVID‐19 outbreak by dividing the total deaths from all causes for weeks 11–21 in 2020 (9 March – 24 May) by the mean number of deaths for the weeks 11–21 averaged over 5 years (2014–2018) (limited to years when comparable Australian data were available). We calculated age and sex stratified relative risks as there are well documented differences in COVID‐19 fatality by age and sex. To estimate the baseline risk of all‐cause mortality in the Australian population, we estimated the mean number of deaths by age and sex for weeks 11–21 over the period 2014–2018. Finally, to estimate the total deaths that might have occurred if Australia had experienced a similar outbreak to England and Wales, we multiplied the baseline expected number of deaths by the age‐specific relative risks for men and women (Box). This resulted in an estimated additional 16 313 deaths in Australia: 9295 men and 7018 women. In contrast, by 26 May 2020 there had been 102 COVID‐19‐attributed deaths in Australia and 1365 excess total deaths from weeks 11 to 21 according to provisional mortality statistics. This enormous difference underlies the importance of Australia’s response using a combination of extensive testing and contact tracing, mandatory quarantine of people returning from overseas, and shutdowns to control community transmission. While acknowledging that these measures carry with them substantial social and economic harms, we wish to highlight the scale of the loss of life avoided. Further details of our methods and results are available in InSight+. Calculated as deaths in 2020 (weeks 11–21)/average deaths in the same period 2014–2018. Weeks 11–21. Average deaths in Australia × RR. If outbreak in Australia had been similar to the United Kingdom. Calculated as expected deaths minus average deaths. Data source: Office of National Statistics website. Deaths registered weekly in England and Wales, provisional. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales (viewed July 2020). The number of deaths for weeks 11–21 in the period 2014–2018 by age and sex were provided on request from the Australian Bureau of Statistics.

Competing interests

No relevant disclosures.
Age group (years)RR for death in England and Wales* Mean total deaths in Australia, 2014–2018Total expected deaths in similar outbreak Estimated absolute increase in number of deaths §
Males
0–140.86167.2144.3−22.9
15–441.06864.0916.752.7
45–641.462629.43844.71215.3
65–741.473111.64573.31461.7
75–841.624589.47461.72872.3
≥ 851.735118.28834.23716.0
Total1.5716 429.825 774.89295.0
Females
0–140.92127.2116.8−10.3
15–441.10440.2482.442.2
45–641.361670.02265.8595.8
65–741.351960.62640.8680.2
75–841.483714.85493.01778.2
≥ 851.527591.611 523.93932.3
Total1.4615 504.422 522.77018.3

Calculated as deaths in 2020 (weeks 11–21)/average deaths in the same period 2014–2018.

Weeks 11–21.

Average deaths in Australia × RR.

If outbreak in Australia had been similar to the United Kingdom. Calculated as expected deaths minus average deaths. Data source: Office of National Statistics website. Deaths registered weekly in England and Wales, provisional. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales (viewed July 2020). The number of deaths for weeks 11–21 in the period 2014–2018 by age and sex were provided on request from the Australian Bureau of Statistics.

  4 in total

1.  Exploring the COVID-19 pandemic experience of maternity clinicians in a high migrant population and low COVID-19 prevalence country: A qualitative study.

Authors:  Sarah J Melov; Nelma Galas; Julie Swain; Thushari I Alahakoon; Vincent Lee; N Wah Cheung; Terry McGee; Dharmintra Pasupathy; Justin McNab
Journal:  Women Birth       Date:  2021-11-05       Impact factor: 3.349

2.  A cross-sectional investigation of the mental health and wellbeing among individuals who have been negatively impacted by the COVID-19 international border closure in Australia.

Authors:  Kathina Ali; Matthew Iasiello; Joep van Agteren; Teri Mavrangelos; Michael Kyrios; Daniel B Fassnacht
Journal:  Global Health       Date:  2022-02-08       Impact factor: 4.185

3.  Learning from the pandemic: mortality trends and seasonality of deaths in Australia in 2020.

Authors:  Gabriel Gregory; Lin Zhu; Andrew Hayen; Katy J L Bell
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

4.  The Lasting Effects of the COVID-19 Pandemic on Support for Anti-Democratic Political Systems: A Six-Month Longitudinal Study.

Authors:  Michele Roccato; Silvia Russo; Pasquale Colloca; Nicoletta Cavazza
Journal:  Soc Sci Q       Date:  2021-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.